Global Diabetes Therapies Market Strategies, By Size, By Segments And By Trends


The Diabetes Therapies Market from The Business Research Company, offers a sales Strategies, growth analysis, size, segmentation, geographies, forecast and much more.

Diabetes Therapies Market Characteristics:

The diabetes therapies market consists of manufacturers’ sales of drugs and therapies for treating diabetes. The drugs most commonly used are alpha-glucosidase inhibitors, biguanides/metformin, sulfonylureas, meglitinides and thiazolidinediones. Innovative techniques relating to diabetes therapies research and development include gene editing, and identification of microbial strains for treatment of diabetes. These advances have created new treatments for diabetes.

Checkout Report:

Companies Mentioned in The Diabetes Therapies Market:

·        NOVO NORDISK A/S,

·        Eli Lilly And Company,

·        Sanofi S.A.,

·        Merck & Company, Inc.

Diabetes Therapies Market Size:

The diabetes therapies market size is expected to reach $70 billion by 2023, growing at a CAGR of around 6%. market for diabetes therapies is expected to face certain restraints from several factors such as lack of awareness and high investment costs. One of the key restraints of the market includes-High investment costs – High costs and long payback periods for investment in new diabetes drugs negatively impacted the market during the historic period. The costs for drug approval processes that include multiple phases of clinical trials and screening processes with regulatory bodies such as the US FDA are very high. According to the Tufts Center for the Study of Drug Development, the cost of bringing a new drug from its conception to shelves was about $2.7 billion in 2017, a significant increase from about $320 million in the 1990s. These high costs and uncertainty regarding return on investments for drug development limited the investments by pharmaceutical companies in the development of new diabetic drugs, thus limiting the growth of the market during the historic period.

Request Free Sample Report@

Diabetes Therapies Market Segmentation

The global diabetes therapies market is further segmented based on type and geography.

By Type - The diabetes therapies market is segmented into oral and injectables diabetes therapies market. The injectable drugs segment accounted for the largest share of the diabetic therapies market in 2018 at $32.3 billion. This large share in the market was due to the prices of injectables being higher than for oral drugs. The highest growth is also projected to come from the injectables segment, which is forecast to grow at a CAGR of about 6.9%. Major factors for this growth include increasing access to injectables in developing and some underdeveloped countries. Increasing awareness of diabetes also contribute to this growth.

By Geography - The diabetes therapies market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, the North America diabetes therapies market accounts for the largest share in the diabetes therapies industry, accounting for almost 39% of the global market in 2018. It was followed by Asia Pacific and Western Europe. Going forward, the fastest growth in the diabetic therapies market is predicted for Asia Pacific, where it is expected at grow at a CAGR of almost 12.3%, followed by Africa at a CAGR of almost 6%. The largest country in terms of value in the diabetic therapies market is the USA. China and India are forecast to have the fastest growth at CAGRs of almost 16% and 13% respectively.

Bottom of Form

Avail Discount On Diabetes Therapies Market Report:

Few Chapters from Table Of Content:                          

1.Executive Summary

2.Table of Contents

3.List of Figures

4.List of Tables

5.Report Structure

6.Diabetes Therapies Market Characteristics

7.Diabetes Therapies Market Supply Chain

8.Diabetes Therapies Market Trends and Strategies

9.Diabetes Therapies Market Size And Growth

10.Diabetes Therapies Market Regional Analysis

11.Diabetes Therapies Market Metrics

12. Asia-Pacific Diabetes Therapies Market

13. Western Europe Diabetes Therapies Market

14. Eastern Europe Diabetes Therapies Market

15. North America Diabetes Therapies Market

About The Business Research Company:

The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293


Follow us on LinkedIn: